Stevanato Group S.p.A STVN
NYSE STVN
$19.50 +0.69 (+3.67%)
At close: Oct 22, 2026 · 4:00 PM EDT

Stevanato Group S.p.A (STVN) EBITDA Margin (2020 - 2026)

Updated

Stevanato Group S.p.A (STVN) recorded EBITDA Margin of 19.91% in the quarter ended Jun 30, 2026, down 1.43 percentage points from 21.34% a year earlier and down 2.06 percentage points from the prior quarter.

Analysis

Stevanato Group S.p.A (STVN) EBITDA Margin (2020 - 2026) Analysis & Trends

On a TTM basis, Stevanato Group S.p.A's EBITDA Margin came in at 23.05% as of Jun 30, 2026, up 1.25 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 23.07%, up 2.57 percentage points from the prior year.

  • Annual EBITDA Margin has a five-year change of +1.25 percentage points (years ended Dec 2020 to Dec 2025).
  • Across earlier years, EBITDA Margin came in at 20.50% in the year ended Dec 31, 2024 (-3.76 pp), 24.26% in the year ended Dec 31, 2023 (-0.42 pp), 24.68% in the year ended Dec 31, 2022 (+0.40 pp) and 24.28% in the year ended Dec 31, 2021 (+2.46 pp).
  • The figure for the quarter ended Jun 30, 2026 is the lowest quarterly EBITDA Margin since the quarter ended Jun 30, 2024.
  • On a year-over-year basis, EBITDA Margin rose in six of the last eight quarters, with an average year-over-year change of +0.77 percentage points.
  • Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 6.19 percentage points in the quarter ended Sep 30, 2022, against a drop of 6.41 percentage points in the quarter ended Jun 30, 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at 21.97% (quarter ended Mar 31, 2026), 26.33% (quarter ended Dec 31, 2025) and 23.42% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 250.06 Bn 229.21 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 177.62 Bn 148.71 Bn 7.27 Bn 21.86%
3 Danaher 161.58 Bn 145.40 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 153.84 Bn 134.26 Bn 2.08 Bn 25.90%
5 Medtronic 123.63 Bn 89.50 Bn 6.34 Bn 25.55%
6 Stryker 117.79 Bn 103.90 Bn 4.50 Bn 29.67%
7 Boston Scientific 66.71 Bn 61.72 Bn 3.85 Bn 28.17%
8 Becton Dickinson 54.60 Bn 51.75 Bn 2.32 Bn 24.62%
9 Edwards Lifesciences 51.95 Bn 36.07 Bn 1.35 Bn 31.93%
10 Stevanato Group S.p.A 5.91 Bn 5.35 Bn 100.91 Mn 20.94%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.94%
Mar 31, 2026 23.17%
Dec 31, 2025 27.33%
Sep 30, 2025 24.57%
Jun 30, 2025 22.47%
Mar 31, 2025 21.53%
Dec 31, 2024 26.17%
Sep 30, 2024 21.40%
Jun 30, 2024 18.81%
Mar 31, 2024 19.90%
Dec 31, 2023 26.22%
Sep 30, 2023 26.42%
Jun 30, 2023 25.22%
Mar 31, 2023 24.80%
Dec 31, 2022 27.45%
Sep 30, 2022 24.69%
Jun 30, 2022 23.97%
Mar 31, 2022 23.41%
Dec 31, 2021 23.72%
Sep 30, 2021 18.49%
API Access

Stevanato Group S.p.A EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=STVN&period=max&api_key=YOUR_API_KEY